The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Voznyuk I.A.

Pavlov First Saint Petersburg State Medical University;
Immanuel Kant Baltic Federal University

Illarioshkin S.N.

Research Center of Neurology

Tkacheva O.N.

Pirogov Russian National Research Medical University

Bogolepova A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies

Vasenina E.E.

Russian Gerontological Scientific and Clinical Center of Pirogov Russian National Research Medical University

Gavrilova S.I.

Mental Health Research Centre

Dokukina T.V.

Republican Scientific and Practical Center of Mental Health

Emelin A.Y.

Kirov Military Medical Academy

Lobzin V.Y.

Kirov Military Medical Academy;
Mechnikov North-Western State Medical University

Mkhitaryan E.A.

Research Center of Neurology

Khatkova S.E.

National Medical Research Center «Treatment and Rehabilitation Center»

Yakushin M.A.

Moscow Regional Research and Clinical Institute;
Semashko National Research Institute of Public Health

Yanishevsky S.N.

Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation

Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023)

Authors:

Levin O.S., Voznyuk I.A., Illarioshkin S.N., Tkacheva O.N., Bogolepova A.N., Vasenina E.E., Gavrilova S.I., Dokukina T.V., Emelin A.Y., Lobzin V.Y., Mkhitaryan E.A., Khatkova S.E., Yakushin M.A., Yanishevsky S.N.

More about the authors

Views: 5458

Downloaded: 294


To cite this article:

Levin OS, Voznyuk IA, Illarioshkin SN, et al. . Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023). S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(9):121‑130. (In Russ.)
https://doi.org/10.17116/jnevro2023123091121

Recommended articles:
Glymphatic dysfunction and sleep diso­rders: indi­rect effe­cts on Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):7-12
Prevalence of cognitive impairment in older adults in the Russian Fede­ration. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11
Cognitive impairment in cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16
Cognitive impairment in patients with arte­rial hype­rtension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48
EEG changes in patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):72-76
Drug-induced cognitive impairment and deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):77-85

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.